Compare NeoGenomics Inc. Common Stock (NEO) vs PPL Corporation Common Stock (PPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs PPL Corporation Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while PPL Corporation Common Stock trades at $34.99 (market cap $26.06B). The key difference: PPL Corporation Common Stock is far larger — about 12.2× NeoGenomics Inc. Common Stock's market cap, and PPL Corporation Common Stock pays a 3.29% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and PPL Corporation Common Stock for 5 Days on average.
| NEO | PPL | |
|---|---|---|
Market Cap | $2.14B | $26.06B |
Volume | 2,228,400 | 5,432,693 |
Sector | Health | Utilities |
52-Week High | $19.91 | $39.81 |
52-Week Low | $7.19 | $31.97 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $2.44B | $46.05B |
Dividend Yield | — | 3.29% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PPL Corporation trades at $34.63, up 0.84% with a bullish technical outlook supported by moving averages. The utility company shows solid fundamentals with $9.04B revenue, 13.47% net margin, and consistent earnings beats in recent quarters. Analyst consensus is strongly bullish with a $39.45 price target, representing 14% upside potential from current levels. Recent news highlights PPL's $23B infrastructure investment plan and focus on meeting rising electricity demand through strategic capacity expansion.
PPL presents a compelling investment case with strong analyst support, dividend growth potential, and strategic positioning in the growing utility sector. Key risks include execution challenges from the massive capital expenditure program, regulatory hurdles, and competitive pressures. The stock's current valuation at 20.49 P/E appears reasonable given the company's growth trajectory and defensive characteristics in the utility space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About PPL Corporation Common Stock
PPL Corporation is a regulated utility holding company. Through its subsidiaries, it generates, transmits, distributes, and sells electricity and natural gas in Kentucky, Pennsylvania, and Rhode Island.
Read more on PPL →
